Lataa...
New HSP27 inhibitors efficiently suppress drug resistance development in cancer cells
Drug resistance is an important open problem in cancer treatment. In recent years, the heat shock protein HSP27 (HSPB1) was identified as a key player driving resistance development. HSP27 is overexpressed in many cancer types and influences cellular processes such as apoptosis, DNA repair, recombin...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5356546/ https://ncbi.nlm.nih.gov/pubmed/27626687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.11905 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|